Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Kando | 2024 | Series Unknown | $10.0M | Kokhav Ya'ir |
| Scentian Bio | 2024 | Non Equity Assistance | $150K | Auckland |
| ProTag | 2024 | Grant | $7K | Auckland |
| Blue Tree Technologies Ltd. | 2024 | Seed | $2.3M | Kiryat Gat |
| CytoReason | 2024 | Series B | $80.0M | Tel Aviv |
| The Bouqs Company | 2024 | Series Unknown | $23.0M | Los Angeles |
| Sapro-Tech | 2024 | Grant | $28K | Parnell |
| Metrovate | 2024 | Seed | $604K | Auckland |
| Jooules | 2024 | Grant | $21K | Wellington |
| ProFuse Technology | 2024 | Grant | $2.6M | Qiryat Shmona |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Kando | Series Unknown | $10.0M | Kokhav Ya'ir, Israel |
| 52 | Scentian Bio | Non Equity Assistance | $150K | Auckland, New Zealand |
| 53 | ProTag | Grant | $7K | Auckland, New Zealand |
| 54 | Blue Tree Technologies Ltd. | Seed | $2.3M | Kiryat Gat, Israel |
| 55 | CytoReason | Series B | $80.0M | Tel Aviv, Israel |
| 56 | The Bouqs Company | Series Unknown | $23.0M | Los Angeles, United States |
| 57 | Sapro-Tech | Grant | $28K | Parnell, New Zealand |
| 58 | Metrovate | Seed | $604K | Auckland, New Zealand |
| 59 | Jooules | Grant | $21K | Wellington, New Zealand |
| 60 | ProFuse Technology | Grant | $2.6M | Qiryat Shmona, Israel |
Kando provides wastewater intelligence solutions for optimizing treatment processes.
Scentian Bio operates as a platform that provides ultimate sensing solution.
ProTag detects illness in livestock early with its smart ear tags.
Blue Tree’s mission is to develop a sugar reduction platform for industrial applications in the drinks industry.
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.
The Bouqs Company is a cut-to-order online flower delivery service.
Sapro-Tech is a provider of sustainable leather from fungi intended to make handbags.
Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
Jooules offers a sustainable food system to ensure a greener, healthier future.
ProFuse Technology revolutionizes cultured meat production.
NeuReality is a semiconductor start-up that designs AI-as-a-service infrastructure.
The Intelligence Platform for Tree's
Sequentify develops sample processing technologies and solutions for next-generation sequencing, genomic diagnostics, and therapeutics.
CorrActions is a software-based platform that's used in a product with human-machine interaction.
A 3D digital twin of Earth I powered by satellite data & artificial intelligence
Xage Security blocks cyberattacks, secures local and remote access, and protects all assets across the enterprise.
MAOLAC is a nutrition products company that offers functional milk proteins.
ThetaRay develops a transaction monitoring platform to identify signs of money laundering.
Intuition Robotics developes AI companions for older adults, fostering independence, connection, and lasting daily engagement.
Cybersecurity, Cyber Threat Intelligence, Deep & Dark Web Monitoring, SaaS
Perception Point provides cybersecurity for threat detection and response in finance, healthcare, and education sectors.
IronVest is a security and privacy-first app designed to protect your online accounts, data, and privacy.
enVerid Systems provides indoor air quality and HVAC energy-saving technologies for commercial buildings.
Phantom Auto is a software company that offers teleoperation safety solutions and remote operations for logistics vehicles.
H2Pro is a renewable energy company that is working on an efficient green hydrogen production method - E-TAC.
OurCrowd has invested in 123 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OurCrowd's top investment sectors include Artificial Intelligence (AI), Biotechnology, Software, Information Technology, Food and Beverage. The firm invests across 68 different industry categories.
Among tracked funding rounds, CytoReason received $80.0M in a Series B round. OurCrowd's total known invested capital is $1.7B.
OurCrowd's average investment size is $21.2M across its portfolio of 123 companies.
Recent OurCrowd portfolio additions include Kando, Scentian Bio, ProTag, Blue Tree Technologies Ltd., CytoReason. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors